Nitroimidazoles. VI. Syntheses of 1-methyl-2-(1,3,4-thiadiazol-2-yl)-5-nitroimidazole and 1-methyl-2-(1,3,4-oxadiazol-2-yl)-5-nitroimidazole

Starting from readily available 1-methyl-5-nitroimidazole-2-carboxylic acid hydrazide (1), 1-methyl-2-(1,3,4-thiadiazol-2-yl)-5-nitroimidazole (4) and 1-methyl-2-(1,3,4-oxadiazol-2-yl)-5-nitroimidazole (10) were prepared. The reaction of 1 with formic acid gave 1-(1-methyl-5-nitroimidazole-2-carboxyl)-2-(formyl)hydrazine ( 8 ) in high yield. Refluxing of the latter with phosphorus pentasulfide in xylene yielded compound 4 in 50% yield. Reaction of compound 8 with phosphorus pentoxide afforded compound 10 in 60% yield.     

Nitroimidazoles. V . Synthesis of 1-methyl-2-(2-methyl-4-thiazolyl)nitroimidazoles

Reaction of readily available 2-methyl-4-formylthiazole ( 1 ) with glyoxal and ammonia gave 2-(2-methyl-4-thiazolyl)imidazole ( 2 ). Nitration of 2 with a mixture of nitric acid-sulfuric acid at 100° yielded 2-(2-methyl-4-thiazolyl)-4,5-dinitroimidazole ( 3 ) as the sole reaction product, while nitration at 65° afforded 2-(2-methyl-4-thiazolyl)-4-(or 5)-nitroimidazole ( 4 ). N-Methylation of compound 4 in the presence of base gave 1-methyl-2-(2-methyl-4-thiazolyl)4-nitroimidazole ( 6 ), whereas N-methylation with diazomethane afforded 1-methyl-2-(2-methyl-4-thiazolyl)-5-nitroimidazole ( 5 ). N-Methylation of compound 3 yielded 1-methyl-2-(2-methyl-4-thiazolyl)-3,5-dinitroimidazole ( 7 ) in high yield.     

2-甲酰基-3-乙酰基-4-甲基-5-苄氧羰基吡咯的合成

甲酰基乙酰基甲基苄氧羰基吡咯;二甲基乙酰基苄氧羰基吡咯;加成环化;选择性氧化     

合成5-氯-1-甲基-4-硝基咪唑的工艺改进

以草酸二乙酯为原料,经酰胺化、环合、成盐及硝化反应合成了5-氯-1-甲基-4-硝基咪唑,总收率61.3%,其结构经1H NMR, IR和MS表征.本方法有两点改进: (1)在酰胺化反应中用30%～40%甲胺水溶液代替甲胺气体; (2)在成盐反应中直接向环化产物的丙酮溶液加硝酸析出5-氯-1-甲基咪唑硝酸盐晶体.     

1—烷基—2—甲基—4—硝基咪唑类化合物的合成及生物活性

利用固－液相转移催化法合成了７种α，ω－双［１－（２－甲基－４－硝基咪唑基）］烷烃和２０种１－烷基－２－甲基－４－硝基咪唑类化合物，大多数化合物收率在８５％以上。初步生物活性试验结果表明，部分化合物具有一定的抗炎、抗菌、镇痛、镇静或抗脑缺氧活性。     

Synthesis of 3-substituted-4-methyl-5-acetyl-4-thiazoline-2-thione

The reaction of various potassium salts [RNHC(=S)SK, R = N(CH₃)₂, morpholino, piperidino, and hexahydro-1-(1H)-azepinyl] with 3-chloro-2,4-pentanedione in ethanol at 25–30° afforded the 1-acetylacetonyl substitutedaminodithiocarbamates 1–4 [RNHC(=S)SCH(COCH₃)₂]. Under refluxing conditions, the same reactants gave the heterocyclic compounds 5–8. Possible mechanism and supporting ir, nmr and mass spectral data are discussed.     

Nitroimidazoles X . Syntheses of substituted 2-(1-methyl-5-nitro-2-imidazolyl)quinolines

Reduction of substituted-2-nitrobenzaldehyde (1) afforded substituted-2-aminobenzaldehyde (2) . Reaction of compound 2 with 2-acetyl-1-methyl-5-nitroimidazole (3) under basic conditions afforded substituted 2-(1-methyl-5-nitro-2-imidazolyl)quinolines 4 . Reaction of compound 4 (R = X) with hydrogen peroxide in acetic acid afforded compound 5 which was transformed to compound 6 with phosphorus oxychloride.     

Synthesis of new functional derivatives of pyrazolidine from 1-acetyl-3-methyl-5-nitromethyl-2-phenylpyrazolidine

3-Nitromethylpyrazolidine reacts with derivatives of unsaturated acids and reducing agents with the formation of polyfunctional compounds of the pyrazolidine nucleus. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 9, pp. 1365–1369, September, 2006.     

Nitroimidazoles. XII. A simple and efficient synthesis of 1-methyl-5-nitroimidazole-2-acetic acid

Reaction of 1-methyl-5-nitroimidazole-2-carboxyl chloride ( 9 ) with diazomethane afforded 2-diazo-1-(1-memyl-5-nitro-2-imidazolyl)ethanone ( 10 ). Successive rearrangement of compound 10 via Arndt-Eastert rearrangement yielded 1-memyl-5-mtroimidazole-2-acetic acid ( 1 ), which was converted to its corresponding methyl ester 11 with etheral solution of diazomethane.     

1-甲基-4-硝基-5-氯咪唑的合成新工艺研究

1-甲基-4-硝基-5-氯咪唑是合成免疫抑制剂硫唑嘌呤(Azathioprine)的中间体.硫唑嘌呤可抑制人体内淋巴细胞,减少狼疮病人的免疫复合物在肾脏的沉积,抑制局部炎症.同时用于治疗类风湿关节炎、各种血管炎、多发性肌炎皮肌炎及系统性红斑狼疮等.     

A novel transformation of 2-dichloracetamido-1-methyl-5-nitroimidazole to 5-dichloroacetylimino-tetrahydroimidazo (4,5-c) pyrazoles.

2-Dichloracetamido-1-methyl-5-nitroimidazole undergoes novel cycloaddition with diazomethane to form 5-dichloracetylimino-tetrahydroimidazopyrazoles via 2-dichloracetylimino-1,3-dimethyl-5-nitroimidazoline.